| Period Ending | 31-Dec-2011 | 31-Dec-2010 | 31-Dec-2009 | 31-Dec-2008 |
|---|
|
Total Revenue
|
47,849,000
|
38,833,000
|
30,745,000
|
29,774,000
| | Cost of Revenue | 28,637,000 | 25,790,000 | 23,110,000 | 22,486,000 | | |
Gross Profit
|
19,212,000
|
13,043,000
|
7,635,000
|
7,288,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 32,940,000 | 34,116,000 | 37,791,000 | 31,264,000 | | | |
Operating Income or Loss
|
14,909,000
|
4,717,000
|
(7,046,000)
|
(1,490,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 14,909,000 | 4,717,000 | (7,046,000) | (1,490,000) |
|
Interest Expense | (1,206,000) | (1,022,000) | (944,000) | (725,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 5,337,000 | 2,018,000 | 1,172,000 | (2,079,000) |
|
Minority Interest | (342,000) | (381,000) | (417,000) | (324,000) |
|
|
|
Net Income From Continuing Ops | 11,624,000 | 1,018,000 | (2,345,000) | (15,979,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
| 198,000 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
11,282,000
|
637,000
|
(2,762,000)
|
(16,105,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.15%